Pathogenic mutations causing LBSL affect mitochondrial aspartyl-tRNA synthetase in diverse ways - PubMed (original) (raw)
. 2013 Mar 1;450(2):345-50.
doi: 10.1042/BJ20121564.
Affiliations
- PMID: 23216004
- DOI: 10.1042/BJ20121564
Pathogenic mutations causing LBSL affect mitochondrial aspartyl-tRNA synthetase in diverse ways
Laura van Berge et al. Biochem J. 2013.
Abstract
The autosomal recessive white matter disorder LBSL (leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation) is caused by mutations in DARS2, coding for mtAspRS (mitochondrial aspartyl-tRNA synthetase). Generally, patients are compound heterozygous for mutations in DARS2. Many different mutations have been identified in patients, including several missense mutations. In the present study, we have examined the effects of missense mutations found in LBSL patients on the expression, enzyme activity, localization and dimerization of mtAspRS, which is important for understanding the cellular defect underlying the pathogenesis of the disease. Nine different missense mutations were analysed and were shown to have various effects on mtAspRS properties. Several mutations have a direct effect on the catalytic activity of the enzyme; others have an effect on protein expression or dimerization. Most mutations have a clear impact on at least one of the properties of mtAspRS studied, probably resulting in a small contribution of the missense variants to the mitochondrial aspartylation activity in the cell.
Similar articles
- Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell-type-dependent splicing of mtAspRS mRNA.
van Berge L, Dooves S, van Berkel CG, Polder E, van der Knaap MS, Scheper GC. van Berge L, et al. Biochem J. 2012 Feb 1;441(3):955-62. doi: 10.1042/BJ20110795. Biochem J. 2012. PMID: 22023289 - Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy.
van Berge L, Hamilton EM, Linnankivi T, Uziel G, Steenweg ME, Isohanni P, Wolf NI, Krägeloh-Mann I, Brautaset NJ, Andrews PI, de Jong BA, al Ghamdi M, van Wieringen WN, Tannous BA, Hulleman E, Würdinger T, van Berkel CG, Polder E, Abbink TE, Struys EA, Scheper GC, van der Knaap MS; LBSL Research Group. van Berge L, et al. Brain. 2014 Apr;137(Pt 4):1019-29. doi: 10.1093/brain/awu026. Epub 2014 Feb 24. Brain. 2014. PMID: 24566671 - DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis.
Isohanni P, Linnankivi T, Buzkova J, Lönnqvist T, Pihko H, Valanne L, Tienari PJ, Elovaara I, Pirttilä T, Reunanen M, Koivisto K, Marjavaara S, Suomalainen A. Isohanni P, et al. J Med Genet. 2010 Jan;47(1):66-70. doi: 10.1136/jmg.2009.068221. Epub 2009 Jul 9. J Med Genet. 2010. PMID: 19592391 - Mitochondrial syndromes with leukoencephalopathies.
Wong LJ. Wong LJ. Semin Neurol. 2012 Feb;32(1):55-61. doi: 10.1055/s-0032-1306387. Epub 2012 Mar 15. Semin Neurol. 2012. PMID: 22422207 Review. - Adult-onset leukoencephalopathy with brain stem and spinal cord involvement in Chinese Han population: a case report and literature review.
Cheng FB, Shen PP, Zhou HW, Meng HM, Yang Y, Feng JC. Cheng FB, et al. Neurol India. 2013 Mar-Apr;61(2):161-3. doi: 10.4103/0028-3886.111123. Neurol India. 2013. PMID: 23644316 Review.
Cited by
- Targeted degradation of extracellular mitochondrial aspartyl-tRNA synthetase modulates immune responses.
Johnson BS, Farkas D, El-Mergawy R, Adair JA, Elhance A, Eltobgy M, Coan FM, Chafin L, Joseph JA, Cornwell A, Johns FJ, Rosas L, Rojas M, Farkas L, Bednash JS, Londino JD, Ray P, Ray A, Kagan V, Lee JS, Chen BB, Mallampalli RK. Johnson BS, et al. Nat Commun. 2024 Jul 22;15(1):6172. doi: 10.1038/s41467-024-50031-7. Nat Commun. 2024. PMID: 39039092 Free PMC article. - Leukoencephalopathy with Brain stem and Spinal cord involvement and Lactate elevation (LBSL): Report of a new family and a novel DARS2 mutation.
Huang WL, Steenari MR, Barrick R, Simon MT, Chang R, Eftekharian SS, Stover A, Schwartz PH, Latini A, Abdenur JE. Huang WL, et al. Mol Genet Metab Rep. 2023 Dec 2;38:101025. doi: 10.1016/j.ymgmr.2023.101025. eCollection 2024 Mar. Mol Genet Metab Rep. 2023. PMID: 38125072 Free PMC article. - Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.
Guang S, O'Brien BM, Fine AS, Ying M, Fatemi A, Nemeth CL. Guang S, et al. Sci Rep. 2023 Aug 10;13(1):13042. doi: 10.1038/s41598-023-40107-7. Sci Rep. 2023. PMID: 37563224 Free PMC article. - Recessive aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models.
Kalotay E, Klugmann M, Housley GD, Fröhlich D. Kalotay E, et al. Front Neurosci. 2023 May 9;17:1182874. doi: 10.3389/fnins.2023.1182874. eCollection 2023. Front Neurosci. 2023. PMID: 37274208 Free PMC article. Review. - Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing.
Guang S, O'Brien B, Fine AS, Ying M, Fatemi A, Nemeth C. Guang S, et al. Res Sq [Preprint]. 2023 Feb 27:rs.3.rs-2603446. doi: 10.21203/rs.3.rs-2603446/v1. Res Sq. 2023. PMID: 36909591 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical